Chronic myeloid leukemia (CML) is a type of stem cell-derived hematopoietic cancer marked through a t (9;22) (q34;q11) chromosome translocation that gives rise to the oncogenic fusion gene bcr-abl. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.